Shenkang VII Recipe Attenuates Unilateral Ureteral Obstruction-induced Renal Fibrosis via TGF-β/Smad, NF-κB and SHH Signaling Pathway
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Biochemistry
Link
http://link.springer.com/content/pdf/10.1007/s11596-020-2255-4.pdf
Reference59 articles.
1. Liu JH, He L, Zou ZM, et al. A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-βl-Induced EMT in Vivo and in Vitro. Kidney Blood Press Res, 2018,43(5):1677–1687
2. Humphreys BD.. Mechanisms of Renal Fibrosis. Annu Rev Physiol, 2018,80:309–326
3. Tang PM, Nikolic-Paterson DJ, Lan HY. Macrophages: versatile players in renal inflammation and fibrosis. Nat Rev Nephrol, 2019,15(3):144–158
4. Yu Y, Feng XH. TGF-β signaling in cell fate control and cancer. Curr Opin Cell Biol, 2019,61:56–63
5. Lan HY. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. Int J Biol Sci, 2011,7(7):1056–1067
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PDGFβ receptor-targeted delivery of truncated transforming growth factor β receptor type II for improving the in vitro and in vivo anti-renal fibrosis activity via strong inactivation of TGF-β1/Smad signaling pathway;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-07-04
2. Acteoside alleviates UUO-induced inflammation and fibrosis by regulating the HMGN1/TLR4/TREM1 signaling pathway;PeerJ;2023-01-18
3. Therapeutic effect and underlying mechanism of Shenkang injection against cisplatin–induced acute kidney injury in mice;Journal of Ethnopharmacology;2023-01
4. Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis;Frontiers in Pharmacology;2022-06-13
5. Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-β1/Smad2/3 and NF-kB/NLRP3 signaling axis in mice;Life Sciences;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3